Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group
- PMID: 3449477
- DOI: 10.1002/hed.2890100105
Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group
Abstract
Between March 1973 and June 1979, patients with advanced operable squamous cell carcinoma of the supraglottic larynx or hypopharynx were randomly allocated to receive either preoperative radiation therapy (5,000 rad) or postoperative radiation therapy (6,000 rad). Patients with oral cavity or oropharynx lesions were randomly assigned either preoperative radiation, postoperative radiation, or definitive radiation therapy (6,500-7,000 rad), with surgery reserved for salvage if residual disease was present 6 weeks after completion of irradiation. Three hundred twenty patients were evaluable with a median follow-up of 60 months. Based on results in 277 patients across all four regions combined, locoregional control was significantly better for patients assigned to receive postoperative radiation therapy (65%) compared with those assigned to receive preoperative radiation therapy (48%, P = 0.04). This was due to a higher rate of both persistent and recurrent local and regional disease in the preoperative group. Survival also showed a trend to be better in the postoperative group (38%) compared with the preoperative group (33%, P = 0.10). Rates of severe surgical and radiation therapy complications were similar overall. Forty-three patients were evaluable for each of the three treatment regimens assigned to patients with oral cavity or oropharynx lesions. Due to the small number of patients available for this portion of the trial, the observed differences for overall survival (4-year percentage 33% overall; 30% preoperative, 36% postoperative, 33% definitive radiation therapy) and for locoregional control (45% overall; 43% preoperative, 52% postoperative, 38% definitive radiation therapy) were not statistically significant. The use of definitive radiation therapy with surgical rescue as an ethically justified alternative treatment for these tumors remains a question for further research.
Similar articles
-
Randomized preoperative and postoperative radiation therapy for patients with carcinoma of the head and neck: preliminary report.Laryngoscope. 1980 Jun;90(6 Pt 1):930-45. doi: 10.1002/lary.1980.90.6.930. Laryngoscope. 1980. PMID: 7382709 Clinical Trial.
-
Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03.Int J Radiat Oncol Biol Phys. 1991 Jan;20(1):21-8. doi: 10.1016/0360-3016(91)90133-o. Int J Radiat Oncol Biol Phys. 1991. PMID: 1993628 Clinical Trial.
-
Comparison of preoperative and postoperative radiation therapy for patients with carcinoma of the head and neck. Interim report.Acta Otolaryngol. 1981 May-Jun;91(5-6):611-26. doi: 10.3109/00016488109138548. Acta Otolaryngol. 1981. PMID: 7270130 Clinical Trial.
-
Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).Radiology. 2003 Sep;228(3):789-94. doi: 10.1148/radiol.2283012044. Radiology. 2003. PMID: 12954897
-
An Updated Review on Head and Neck Cancer Treatment with Radiation Therapy.Cancers (Basel). 2021 Sep 30;13(19):4912. doi: 10.3390/cancers13194912. Cancers (Basel). 2021. PMID: 34638398 Free PMC article. Review.
Cited by
-
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.BMC Cancer. 2015 Aug 27;15:602. doi: 10.1186/s12885-015-1598-x. BMC Cancer. 2015. PMID: 26311526 Free PMC article. Clinical Trial.
-
De-Escalation Strategies in HPV-Associated Oropharynx Cancer: A Historical Perspective with Future Direction.Cancers (Basel). 2024 Aug 1;16(15):2733. doi: 10.3390/cancers16152733. Cancers (Basel). 2024. PMID: 39123461 Free PMC article. Review.
-
Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck Cancer.J Stroke. 2018 Jan;20(1):71-79. doi: 10.5853/jos.2017.01802. Epub 2018 Jan 31. J Stroke. 2018. PMID: 29402065 Free PMC article.
-
Alimentation impact of treatments of 254 oropharyngeal cancers (1998-2003).ISRN Surg. 2011;2011:609517. doi: 10.5402/2011/609517. Epub 2011 May 14. ISRN Surg. 2011. PMID: 22084765 Free PMC article.
-
Induction Chemotherapy in Low-Risk HPV+ Oropharyngeal Cancer.Curr Treat Options Oncol. 2022 Jan;23(1):54-67. doi: 10.1007/s11864-022-00941-9. Epub 2022 Feb 16. Curr Treat Options Oncol. 2022. PMID: 35171457 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical